Clinical research is a dynamic field at the forefront of medical advancements. It plays a crucial role in developing safe and effective therapies that have the potential to transform healthcare. Within this landscape, Advarra Integrated Solutions has emerged as a leading force, specializing in a comprehensive suite of services, including Institutional Review Boards (IRB) and critical support functions. As the largest integrated IRB services provider with a vast network, Advarra is a prominent player in this vital domain.
Advarra Integrated Solutions, a pioneering leader in clinical research, is committed to advancing ethical, compliant, and efficient therapy development. Their comprehensive suite encompasses IRB services, consulting, technology, and professional support, establishing them as a leading provider in the field. At the heart of their industry leadership lies the Center for IRB Intelligence Platform (CIRBI), which powers highly experienced Data Monitoring Committee (DMC) and Event Adjudication Committee (EAC) services, supported by a global network of over 1,500 experts.
Our passion drives us at Advarra to ensure safety, ethics, and efficiency in advancing life-changing therapies. Together with our partners, we are on a mission to shape the future of clinical research to benefit patients worldwide. – Gadi Saarony, CEO
Advarra’s contributions to clinical research reach far beyond its services. Collaborating with IQVIA, a leader in human data science, Advarra’s efficient IRB and Institutional Biosafety Committee (IBC) reviews, coupled with its Gene Therapy Ready site network, expedited therapeutic development. Furthermore, partnering with Inova Health System and implementing Advarra’s eRegulatory Management System resulted in a remarkable 20% boost in regulatory efficiency without increasing staff. These collaborations exemplify Advarra’s tangible and practical benefits to the clinical research community.
The University of Wisconsin Carbone Cancer Center leveraged Advarra’s data analytics and visualization capabilities through Advarra Insights. This enhanced its research data management, ultimately contributing to more effective decision-making and research operations.
In an era focused on groundbreaking medical advancements, Advarra played a pivotal role on the institutional review board (IRB) for a phase I trial of an mRNA vaccine against SARS-CoV-2, contributing significantly to combating a global health threat and advancing human health. Advarra’s reach in clinical research spans various domains, with institutions, hospitals, health systems, and academic medical centers placing their trust in the organization, solidifying its status as a trusted partner in the clinical research landscape.
The impact of Advarra’s services is vividly demonstrated in the Operation Warp Speed vaccine trials, where 100% of these trials received support from Advarra’s IRB and IBC services. Their unwavering commitment to safety and compliance played a crucial role in expediting these pivotal vaccine trials.
Furthermore, Advarra’s technological expertise is highly regarded, with 78% of National Cancer Institute (NCI)-designated Cancer Centers utilizing Advarra Technology. This underscores its crucial role in cancer research and the development of treatments for one of the world’s most prevalent diseases.
Advarra’s influence extends to investigators worldwide, with an impressive 50,000 investigators utilizing Advarra technology solutions to support its research. These investigators understand the value of Advarra’s offerings in streamlining research processes and ensuring compliance, ultimately accelerating the development of life-changing therapies.
Advarra offers a comprehensive suite of services, including consulting, technology solutions, and professional support, all designed to enhance the efficiency of clinical research. Operating globally, Advarra tailors solutions for diverse stakeholders, including sponsors, CROs, clinical sites, and investigators, with a mission to expedite advancements in human health. Their unwavering commitment to safety, compliance, and efficiency significantly impacts patient lives and medical science progress. Advarra’s innovative solutions and dedication make it a trusted partner for institutions worldwide, leading the charge toward a future where accessible, safe, and effective treatments are paramount in a precision-driven field.
